Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant has commercially launched Guardant360®, Guardant360® CDx, Guardant360 TissueNext™, and Guardant360 Response™ tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes